2024-09-16 |
2024-09-12 |
PP
Planned purchase
|
Angulo Gonzalez David
Chief Executive Officer
Executive Director
|
20,000
+4.1%
1.37
USD 27,400
|
20,000
+4.1%
|
1.37
|
USD 27,400
|
|
2022-04-28 |
2022-04-26 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
75,000
+38.1%
3.00
USD 225,000
|
75,000
+38.1%
|
3.00
|
USD 225,000
|
|
2022-04-28 |
2022-04-26 |
B
Purchase
|
Sukenick Scott
General Counsel
Officer
|
3,500
+7.0%
3.00
USD 10,500
|
3,500
+7.0%
|
3.00
|
USD 10,500
|
|
2021-01-26 |
2021-01-22 |
S
Sale
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
33,849
-1.8%
8.95
USD 302,949
|
33,849
-1.8%
|
8.95
|
USD 302,949
|
|
2021-01-26 |
2021-01-22 |
S
Sale
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
285,151
-13.5%
8.16
USD 2,326,832
|
285,151
-13.5%
|
8.16
|
USD 2,326,832
|
|
2021-01-26 |
2021-01-21 |
S
Sale
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
95,000
-4.3%
7.38
USD 701,100
|
95,000
-4.3%
|
7.38
|
USD 701,100
|
|
2021-01-26 |
2021-01-20 |
S
Sale
|
PERCEPTIVE ADVISORS LLC
Large shareholder
|
185,000
-7.7%
7.43
USD 1,374,550
|
185,000
-7.7%
|
7.43
|
USD 1,374,550
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
ANIDO ARMANDO
Non-Executive Director
|
5,000
+inf%
6.25
USD 31,250
|
5,000
+inf%
|
6.25
|
USD 31,250
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
HANHAM ANN
Non-Executive Director
|
3,200
+758.3%
6.25
USD 20,000
|
3,200
+758.3%
|
6.25
|
USD 20,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Francois Eric
Chief Financial Officer
Officer
|
600
+5.4%
6.25
USD 3,750
|
600
+5.4%
|
6.25
|
USD 3,750
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Tinmouth Brian Philippe
Non-Executive Director
|
8,000
+inf%
6.25
USD 50,000
|
8,000
+inf%
|
6.25
|
USD 50,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
40,000
+57.4%
6.25
USD 250,000
|
40,000
+57.4%
|
6.25
|
USD 250,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Sukenick Scott
General Counsel
Officer
|
1,600
+21.3%
6.25
USD 10,000
|
1,600
+21.3%
|
6.25
|
USD 10,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Macdonald Guy
Non-Executive Director
|
8,000
+200.0%
6.25
USD 50,000
|
8,000
+200.0%
|
6.25
|
USD 50,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
GILMAN STEVEN C
Non-Executive Director
|
4,000
+inf%
6.25
USD 25,000
|
4,000
+inf%
|
6.25
|
USD 25,000
|
|
2020-12-23 |
2020-12-21 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
1,600
+7.2%
6.25
USD 10,000
|
1,600
+7.2%
|
6.25
|
USD 10,000
|
|
2019-12-16 |
2019-12-12 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
166,667
+31.6%
0.90
USD 150,000
|
166,667
+31.6%
|
0.90
|
USD 150,000
|
|
2019-08-22 |
2019-08-21 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
9,500
+1.8%
1.11
USD 10,545
|
9,500
+1.8%
|
1.11
|
USD 10,545
|
|
2019-08-22 |
2019-08-20 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
500
+0.1%
1.11
USD 555
|
500
+0.1%
|
1.11
|
USD 555
|
|
2019-08-19 |
2019-08-15 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
10,015
+2.0%
1.01
USD 10,115
|
10,015
+2.0%
|
1.01
|
USD 10,115
|
|
2019-04-18 |
2019-04-17 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+5.2%
1.63
USD 40,750
|
25,000
+5.2%
|
1.63
|
USD 40,750
|
|
2019-01-14 |
2019-01-10 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+5.5%
0.69
USD 17,250
|
25,000
+5.5%
|
0.69
|
USD 17,250
|
|
2019-01-02 |
2018-12-31 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+5.8%
0.46
USD 11,500
|
25,000
+5.8%
|
0.46
|
USD 11,500
|
|
2019-01-02 |
2018-12-31 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
12,000
+10.9%
0.50
USD 5,951
|
12,000
+10.9%
|
0.50
|
USD 5,951
|
|
2018-09-10 |
2018-09-06 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
7,000
+6.9%
1.27
USD 8,890
|
7,000
+6.9%
|
1.27
|
USD 8,890
|
|
2018-08-27 |
2018-08-23 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+6.2%
1.29
USD 32,250
|
25,000
+6.2%
|
1.29
|
USD 32,250
|
|
2018-04-02 |
2018-03-29 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
|
6,000
+6.3%
1.36
USD 8,160
|
6,000
+6.3%
|
1.36
|
USD 8,160
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
HASTINGS DAVID C
|
11,834
+59.2%
1.69
USD 19,999
|
11,834
+59.2%
|
1.69
|
USD 19,999
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
Sukenick Scott
General Counsel
|
2,959
+inf%
1.69
USD 5,001
|
2,959
+inf%
|
1.69
|
USD 5,001
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
Francois Eric
Chief Financial Officer
|
5,917
+31.1%
1.69
USD 10,000
|
5,917
+31.1%
|
1.69
|
USD 10,000
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
|
14,790
+20.0%
1.69
USD 24,995
|
14,790
+20.0%
|
1.69
|
USD 24,995
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
100,000
+32.9%
1.69
USD 169,000
|
100,000
+32.9%
|
1.69
|
USD 169,000
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
|
7,000
+7.9%
1.39
USD 9,730
|
7,000
+7.9%
|
1.39
|
USD 9,730
|
|
2017-09-25 |
2017-09-22 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
10,000
+3.4%
2.23
USD 22,300
|
10,000
+3.4%
|
2.23
|
USD 22,300
|
|
2017-08-24 |
2017-08-23 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
4,993
+1.7%
1.85
USD 9,237
|
4,993
+1.7%
|
1.85
|
USD 9,237
|
|
2017-08-24 |
2017-08-22 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
7
+0.0%
1.61
USD 11
|
7
+0.0%
|
1.61
|
USD 11
|
|
2017-08-17 |
2017-08-15 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
10,000
+3.6%
1.61
USD 16,100
|
10,000
+3.6%
|
1.61
|
USD 16,100
|
|
2017-08-14 |
2017-08-11 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
|
10,000
+16.1%
1.55
USD 15,500
|
10,000
+16.1%
|
1.55
|
USD 15,500
|
|
2017-06-22 |
2017-06-21 |
B
Purchase
|
HASTINGS DAVID C
|
20,000
+inf%
1.75
USD 35,000
|
20,000
+inf%
|
1.75
|
USD 35,000
|
|
2017-05-15 |
2017-05-12 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
15,000
+31.9%
1.70
USD 25,500
|
15,000
+31.9%
|
1.70
|
USD 25,500
|
|
2017-05-15 |
2017-05-12 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+9.9%
1.69
USD 42,250
|
25,000
+9.9%
|
1.69
|
USD 42,250
|
|
2016-12-22 |
2016-12-21 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+11.1%
3.30
USD 82,500
|
25,000
+11.1%
|
3.30
|
USD 82,500
|
|
2016-12-19 |
2016-12-16 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
4,000
+9.5%
3.25
USD 13,000
|
4,000
+9.5%
|
3.25
|
USD 13,000
|
|
2016-09-16 |
2016-09-15 |
B
Purchase
|
Machado Patrick
Non-Executive Director
|
40,000
+200.0%
2.94
USD 117,600
|
40,000
+200.0%
|
2.94
|
USD 117,600
|
|
2016-07-01 |
2016-06-30 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
32,150
+363.3%
2.23
USD 71,695
|
32,150
+363.3%
|
2.23
|
USD 71,695
|
|
2016-07-01 |
2016-06-29 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
4,800
+118.5%
2.18
USD 10,464
|
4,800
+118.5%
|
2.18
|
USD 10,464
|
|
2016-06-28 |
2016-06-24 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
100,000
+80.0%
2.39
USD 239,000
|
100,000
+80.0%
|
2.39
|
USD 239,000
|
|
2016-06-28 |
2016-06-24 |
B
Purchase
|
Francois Eric
Chief Financial Officer
Officer
|
15,000
+inf%
2.39
USD 35,850
|
15,000
+inf%
|
2.39
|
USD 35,850
|
|
2016-06-28 |
2016-06-24 |
B
Purchase
|
Machado Clarence Patrick
Non-Executive Director
|
20,000
+inf%
2.39
USD 47,800
|
20,000
+inf%
|
2.39
|
USD 47,800
|
|
2016-06-28 |
2016-06-24 |
B
Purchase
|
Macdonald Guy
Non-Executive Director
|
40,000
+inf%
2.39
USD 95,600
|
40,000
+inf%
|
2.39
|
USD 95,600
|
|
2016-05-27 |
2016-05-25 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
5,754
+4.8%
3.26
USD 18,758
|
5,754
+4.8%
|
3.26
|
USD 18,758
|
|
2016-05-27 |
2016-05-25 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
246
+0.2%
3.20
USD 787
|
246
+0.2%
|
3.20
|
USD 787
|
|
2016-05-27 |
2016-05-25 |
B
Purchase
|
HANHAM ANN
Non-Executive Director
|
4,225
+inf%
3.64
USD 15,379
|
4,225
+inf%
|
3.64
|
USD 15,379
|
|
2016-05-25 |
2016-05-24 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
5,500
+4.8%
3.37
USD 18,535
|
5,500
+4.8%
|
3.37
|
USD 18,535
|
|
2016-05-24 |
2016-05-23 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
3,000
+2.7%
3.15
USD 9,450
|
3,000
+2.7%
|
3.15
|
USD 9,450
|
|
2016-05-24 |
2016-05-20 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
4,500
+4.2%
3.14
USD 14,130
|
4,500
+4.2%
|
3.14
|
USD 14,130
|
|
2016-05-20 |
2016-05-19 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
6,000
+6.0%
3.07
USD 18,420
|
6,000
+6.0%
|
3.07
|
USD 18,420
|
|
2015-11-24 |
2015-11-24 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
7,733
+8.4%
6.80
USD 52,584
|
7,733
+8.4%
|
6.80
|
USD 52,584
|
|
2015-11-24 |
2015-11-23 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
15,000
+19.4%
6.79
USD 101,850
|
15,000
+19.4%
|
6.79
|
USD 101,850
|
|
2015-09-18 |
2015-09-15 |
B
Purchase
|
Angulo Gonzalez David
Chief Medical Officer
Officer
|
3,000
+inf%
7.00
USD 21,000
|
3,000
+inf%
|
7.00
|
USD 21,000
|
|
2015-09-02 |
2015-08-31 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+47.8%
7.82
USD 195,500
|
25,000
+47.8%
|
7.82
|
USD 195,500
|
|
2015-08-31 |
2015-08-28 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
400
+0.8%
7.15
USD 2,860
|
400
+0.8%
|
7.15
|
USD 2,860
|
|
2015-08-31 |
2015-08-27 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
1,867
+3.7%
7.07
USD 13,200
|
1,867
+3.7%
|
7.07
|
USD 13,200
|
|
2015-08-27 |
2015-08-26 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
25,000
+100.0%
6.98
USD 174,500
|
25,000
+100.0%
|
6.98
|
USD 174,500
|
|
2015-08-27 |
2015-08-25 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
20,000
+400.0%
7.15
USD 143,000
|
20,000
+400.0%
|
7.15
|
USD 143,000
|
|
2015-08-27 |
2015-08-25 |
B
Purchase
|
Taglietti Marco
Chief Executive Officer
Executive Director
|
5,000
+inf%
7.16
USD 35,800
|
5,000
+inf%
|
7.16
|
USD 35,800
|
|
2014-05-09 |
2014-05-07 |
B
Purchase
|
F.C.P.R. Genavent
Large shareholder
|
10,000
+4.4%
10.00
USD 100,000
|
10,000
+4.4%
|
10.00
|
USD 100,000
|
|
2014-05-08 |
2014-05-07 |
B
Purchase
|
Nothias Jean-Yves
Non-Executive Director
|
50,000
+20.4%
10.00
USD 500,000
|
50,000
+20.4%
|
10.00
|
USD 500,000
|
|
2014-05-08 |
2014-05-07 |
B
Purchase
|
Ventech Capital II
Large shareholder
|
28,000
+7.2%
10.00
USD 280,000
|
28,000
+7.2%
|
10.00
|
USD 280,000
|
|
2014-05-08 |
2014-05-07 |
B
Purchase
|
FCPR Biotechnology Fund
Large shareholder
|
50,000
+20.4%
10.00
USD 500,000
|
50,000
+20.4%
|
10.00
|
USD 500,000
|
|
2014-05-08 |
2014-05-07 |
B
Purchase
|
ALTA BIOPHARMA PARTNERS II LP
Large shareholder
|
31,934
+231.4%
10.00
USD 319,340
|
31,934
+231.4%
|
10.00
|
USD 319,340
|
|
2014-05-08 |
2014-05-07 |
B
Purchase
|
ALTA BIOPHARMA PARTNERS II LP
Large shareholder
|
868,066
+233.0%
10.00
USD 8,680,660
|
868,066
+233.0%
|
10.00
|
USD 8,680,660
|
|